search
Back to results

Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial (IDEAL)

Primary Purpose

Ulcerative Colitis, Ileostomy - Stoma

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
ileal pouch-anal anastomosis with diverting loop ileastomy
ileal pouch-anal anastomosis with diverting loop ileastomy
Sponsored by
Assistance Publique Hopitaux De Marseille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Ulcerative Colitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients aged ≥ 18 years,
  • patients presenting with ulcerative colitis or indeterminate colitis requiring completion proctectomy
  • patients who have given informed consent

Exclusion Criteria:

  • indication for total proctocolectomy in one-stage or traditional 2-stage fashion
  • Crohn's disease,
  • pelvic radiotherapy,
  • indication for total mésorectum excision
  • vulnerable patient under the French laws

Sites / Locations

  • Assistance Publique Hôpitaux de MarseilleRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental

Control

Arm Description

ileal pouch-anal anastomosis without diverting loop ileostomy

ileal pouch-anal anastomosis with diverting loop ileostomy

Outcomes

Primary Outcome Measures

6-month global postoperative morbidity
Number and qualification of surgical and medical complications that may require redmission during the 6 months following the operative procedure: SBO ileostomy prolapse parastomial hernia dehydration skin erosions, that may require readmission anastomotic leakage incisional hernia.

Secondary Outcome Measures

Full Information

First Posted
March 11, 2019
Last Updated
February 3, 2023
Sponsor
Assistance Publique Hopitaux De Marseille
search

1. Study Identification

Unique Protocol Identification Number
NCT03872271
Brief Title
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial
Acronym
IDEAL
Official Title
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 26, 2019 (Actual)
Primary Completion Date
May 24, 2024 (Anticipated)
Study Completion Date
May 24, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy. Total proctocolectomy with IPAA is the gold standard for surgical management of ulcerative colitis (UC). This demanding procedure is often performed in 2 or 3 stages, namely subtotal colectomy, completion proctectomy with IPAA and defunctioning ileostomy closure. Subtotal colectomy with double stoma is first performed to allow nutritional support, reduce inflammation and stop immunosuppressive agents. Completion proctectomy with IPAA is then performed on a healthier patient. Hence, the need for a systematic defunctioning ileostomy is questioned. No study addressed specifically the question of completion proctectomy, whereas it concerns 36% to 42% of patients undergoing IPAA. Globally, the overall 6-month morbidity rate is 55% in case of stoma creation vs. 30% otherwise in IPAA. Moreover, defunctioning ileostomy has several drawbacks including an additional surgical procedure (stoma closure), a worse quality of life before closure, and the risk of dehydration that may require readmission. Following stoma closure, the risk of anastomotic leakage is around 4%. Overall, during the stoma period, 8% of patients will require reoperation. Finally, the risk of incisional hernia is 15-20% at the ex-ileostomy site. Therefore, the aim of this trial is to assess the need for a systematic defunctioning ileostomy after completion proctectomy with IPAA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis, Ileostomy - Stoma

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
194 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental
Arm Type
Experimental
Arm Description
ileal pouch-anal anastomosis without diverting loop ileostomy
Arm Title
Control
Arm Type
Active Comparator
Arm Description
ileal pouch-anal anastomosis with diverting loop ileostomy
Intervention Type
Procedure
Intervention Name(s)
ileal pouch-anal anastomosis with diverting loop ileastomy
Intervention Description
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy.
Intervention Type
Procedure
Intervention Name(s)
ileal pouch-anal anastomosis with diverting loop ileastomy
Intervention Description
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy.
Primary Outcome Measure Information:
Title
6-month global postoperative morbidity
Description
Number and qualification of surgical and medical complications that may require redmission during the 6 months following the operative procedure: SBO ileostomy prolapse parastomial hernia dehydration skin erosions, that may require readmission anastomotic leakage incisional hernia.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients aged ≥ 18 years, patients presenting with ulcerative colitis or indeterminate colitis requiring completion proctectomy patients who have given informed consent Exclusion Criteria: indication for total proctocolectomy in one-stage or traditional 2-stage fashion Crohn's disease, pelvic radiotherapy, indication for total mésorectum excision vulnerable patient under the French laws
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura BEYER, MD
Phone
0491968514
Email
laura.beyer@ap-hm.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Amandine Rolland-Brun
Phone
0491381245
Email
promotion.interne@ap-hm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
EMILIE GARRIDO PRADALIE
Organizational Affiliation
AP-HM
Official's Role
Study Director
Facility Information:
Facility Name
Assistance Publique Hôpitaux de Marseille
City
Marseille
ZIP/Postal Code
13354
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Beyer, MD
Email
laura.beyer@ap-hm.fr

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
31830976
Citation
Beyer-Berjot L, Baumstarck K, Loubiere S, Vicaut E, Berdah SV, Benoist S, Lefevre JH; GETAID Chirurgie group. Is diverting loop ileostomy necessary for completion proctectomy with ileal pouch-anal anastomosis? A multicenter randomized trial of the GETAID Chirurgie group (IDEAL trial): rationale and design (NCT03872271). BMC Surg. 2019 Dec 12;19(1):192. doi: 10.1186/s12893-019-0657-7.
Results Reference
derived

Learn more about this trial

Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial

We'll reach out to this number within 24 hrs